Longer-acting human growth hormone (hGH-CTP) receives orphan drug designation in Europe (14 February 2013)

15 Feb 2013


The European Medicines Agency have granted orphan drug status to a longer-acting version of human growth hormone, which is currently being developed as a treatment for growth hormone deficiency.

Full article


Share this story